Kopran Ltd (KOPRAN) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 568367,
    "name": "Kopran",
    "stock_name": "Kopran",
    "full_name": "Kopran Ltd",
    "name_url": "stocks-analysis/kopran",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "180.00",
    "chg": -1.4,
    "chgp": "-0.77%",
    "dir": -1,
    "prev_price": "181.40",
    "mcapval": "844.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524280,
    "symbol": "KOPRAN",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE082A01010",
    "curr_date": "Aug 10",
    "curr_time": "",
    "bse_nse_vol": "1.88 lacs",
    "exc_status": "Active",
    "traded_date": "Aug 10, 2026",
    "traded_date_str": "2026 08 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/kopran-568367-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Kopran Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kopran-ltd-technical-momentum-shifts-amid-mixed-market-signals-4002125",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/KopranLtd_technicaldot_4002125.png",
        "date": "2026-05-21 08:01:57",
        "description": "Kopran Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Despite a recent downgrade in daily moving averages and a 2.93% decline in the stock price, several weekly and monthly technical indicators present a complex picture of the stock’s near-term prospects."
      },
      {
        "title": "Are Kopran Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-kopran-ltd-latest-results-good-or-bad-4001495",
        "imagepath": "",
        "date": "2026-05-20 19:22:52",
        "description": "Kopran Ltd's latest financial results for the quarter ended March 2026 reflect a notable recovery from previous periods, showcasing significant improvements across key metrics. The company reported net sales of ₹234.02 crores, representing a year-on-year growth of 35.77% compared to ₹172.36 crores in the same quarter last year. This growth indicates a robust demand recovery in the pharmaceutical formulations and API segments.\n\nThe net profit for the quarter reached ₹18.87 crores, marking a substantial year-on-year increase of 94.94% from ₹9.68 crores in Q4 FY25. This recovery is particularly striking when considering the company's performance in the preceding September 2025 quarter, where it recorded a net loss of ₹9.92 crores. The operating profit margin also improved significantly, reaching 14.08%, which is the highest margin reported in at least eight quarters, up from 9.91% in the same quarter last year..."
      },
      {
        "title": "Kopran Ltd Technical Momentum Shifts Signal Mildly Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kopran-ltd-technical-momentum-shifts-signal-mildly-bullish-outlook-4000122",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/KopranLtd_technicaldot_4000122.png",
        "date": "2026-05-20 08:02:23",
        "description": "Kopran Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its technical momentum, moving from a mildly bearish to a mildly bullish trend. This change is underscored by a 4.43% gain in the stock price on 20 May 2026, closing at ₹172.25, signalling renewed investor interest amid broader market volatility."
      },
      {
        "title": "Kopran Ltd Reports Strong Quarterly Turnaround with Robust Revenue and Margin Gains",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kopran-ltd-reports-strong-quarterly-turnaround-with-robust-revenue-and-margin-gains-3999975",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/KopranLtd_fintrenddot_3999975.png",
        "date": "2026-05-20 08:00:14",
        "description": "Kopran Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has demonstrated a notable financial turnaround in the quarter ended March 2026, shifting from a negative to a positive growth trajectory. The company’s latest quarterly results reveal record highs in revenue, profitability, and operating efficiency, signalling a potential inflection point after a period of subdued performance."
      }
    ],
    "total": 15,
    "sid": "568367",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/kopran-568367"
  },
  "announcements": [
    {
      "caption": "Result For Q1 FY 2026-27",
      "datetime": "07-Aug-2026",
      "details": "Unaudited Standalone and Consolidated Result for the quarter ended June 30 2026",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Result Q1 FY 2026-27",
      "datetime": "07-Aug-2026",
      "details": "Unaudited Standalone and Consolidated Result for the Quarter Ended June 30 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
      "datetime": "07-Aug-2026",
      "details": "For Q1 FY 2026-27",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Kopran Ltd has declared <strong>30%</strong> dividend, ex-date: 11 Aug 26",
          "dt": "2026-08-11",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Kopran Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-05-21 08:01:57

Kopran Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Despite a recent downgrade in daily moving averages and a 2.93% decline in the stock price, several weekly and monthly technical indicators present a complex picture of the stock’s near-term prospects.

Are Kopran Ltd latest results good or bad?

2026-05-20 19:22:52

Kopran Ltd's latest financial results for the quarter ended March 2026 reflect a notable recovery from previous periods, showcasing significant improvements across key metrics. The company reported net sales of ₹234.02 crores, representing a year-on-year growth of 35.77% compared to ₹172.36 crores in the same quarter last year. This growth indicates a robust demand recovery in the pharmaceutical formulations and API segments. The net profit for the quarter reached ₹18.87 crores, marking a substantial year-on-year increase of 94.94% from ₹9.68 crores in Q4 FY25. This recovery is particularly striking when considering the company's performance in the preceding September 2025 quarter, where it recorded a net loss of ₹9.92 crores. The operating profit margin also improved significantly, reaching 14.08%, which is the highest margin reported in at least eight quarters, up from 9.91% in the same quarter last year...

Kopran Ltd Technical Momentum Shifts Signal Mildly Bullish Outlook

2026-05-20 08:02:23

Kopran Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its technical momentum, moving from a mildly bearish to a mildly bullish trend. This change is underscored by a 4.43% gain in the stock price on 20 May 2026, closing at ₹172.25, signalling renewed investor interest amid broader market volatility.

Kopran Ltd Reports Strong Quarterly Turnaround with Robust Revenue and Margin Gains

2026-05-20 08:00:14

Kopran Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has demonstrated a notable financial turnaround in the quarter ended March 2026, shifting from a negative to a positive growth trajectory. The company’s latest quarterly results reveal record highs in revenue, profitability, and operating efficiency, signalling a potential inflection point after a period of subdued performance.

View All News